These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 825880)

  • 21. Primate information processing under sodium pentobarbital and chlorpromazine: differential drug effects with tachistoscopically presented discriminative stimuli.
    Bartus RT; Johnson HR
    Psychopharmacology (Berl); 1977 Aug; 53(3):249-54. PubMed ID: 408852
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MK-801 impairs recognition memory in rhesus monkeys: comparison with cholinergic drugs.
    Ogura H; Aigner TG
    J Pharmacol Exp Ther; 1993 Jul; 266(1):60-4. PubMed ID: 8331575
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Scopolamine does not disrupt spatial working memory in rats.
    Godding PR; Rush JR; Beatty WW
    Pharmacol Biochem Behav; 1982 Jun; 16(6):919-23. PubMed ID: 7111351
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of scopolamine on learning and memory in monkeys.
    Savage UC; Faust WB; Lambert P; Moerschbaecher JM
    Psychopharmacology (Berl); 1996 Jan; 123(1):9-14. PubMed ID: 8741949
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amnestic drugs in the odor span task: Effects of flunitrazepam, zolpidem and scopolamine.
    Galizio M; Mathews M; Mason M; Panoz-Brown D; Prichard A; Soto P
    Neurobiol Learn Mem; 2017 Nov; 145():67-74. PubMed ID: 28893667
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low dose scopolamine affects discriminability but not rate of forgetting in delayed conditional discrimination.
    Kirk RC; White KG; McNaughton N
    Psychopharmacology (Berl); 1988; 96(4):541-6. PubMed ID: 3149778
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The specific nature of the cholinergic mechanisms of short-term memory in monkeys for different types of visual information: the characteristics of the effect of amizil].
    Dudkin KN; Chueva IV
    Ross Fiziol Zh Im I M Sechenova; 1997 Oct; 83(10):16-23. PubMed ID: 9487080
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Central cholinergic involvement in working memory: effects of scopolamine on continuous nonmatching and discrimination performance in the rat.
    Spencer DG; Pontecorvo MJ; Heise GA
    Behav Neurosci; 1985 Dec; 99(6):1049-65. PubMed ID: 3843539
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Scopolamine affects short-term memory but not inferior temporal neurons.
    Miller EK; Desimone R
    Neuroreport; 1993 Jan; 4(1):81-4. PubMed ID: 8453043
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of scopolamine on memory for time in rats and pigeons.
    Santi A; Weise L
    Pharmacol Biochem Behav; 1995; 51(2-3):271-7. PubMed ID: 7667339
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FK960 [N-(4-acetyl-1-piperazinyl)-p-fluorobenzamide monohydrate], a novel potential antidementia drug, improves visual recognition memory in rhesus monkeys: comparison with physostigmine.
    Matsuoka N; Aigner TG
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1201-9. PubMed ID: 9067304
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of scopolamine on performance of rats in a delayed-response radial maze task.
    Bolhuis JJ; Strijkstra AM; Kramers RJ
    Physiol Behav; 1988; 43(4):403-9. PubMed ID: 3194458
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of scopolamine and unilateral lesions of the basal forebrain on T-maze spatial discrimination and alternation in rats.
    Beninger RJ; Jhamandas K; Boegman RJ; el-Defrawy SR
    Pharmacol Biochem Behav; 1986 May; 24(5):1353-60. PubMed ID: 3725838
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cholinergic drug effects on visual discriminations: a signal detection analysis.
    Milar KS
    Psychopharmacology (Berl); 1981; 74(4):383-8. PubMed ID: 6794087
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of scopolamine and methscopolamine on brightness discrimination reinforced by opportunity for exploration.
    Leaton RN
    J Comp Physiol Psychol; 1969 May; 68(1):155-8. PubMed ID: 5793863
    [No Abstract]   [Full Text] [Related]  

  • 36. The scopolamine-reversal paradigm in rats and monkeys: the importance of computer-assisted operant-conditioning memory tasks for screening drug candidates.
    Buccafusco JJ; Terry AV; Webster SJ; Martin D; Hohnadel EJ; Bouchard KA; Warner SE
    Psychopharmacology (Berl); 2008 Aug; 199(3):481-94. PubMed ID: 17657478
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Scopolamine impairs recall of one-trial stimulus-reward association in monkeys.
    Aigner TG; Mishkin M
    Behav Brain Res; 1993 Apr; 54(2):133-6. PubMed ID: 8323711
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of a neurotensin analogue (PD149163) and antagonist (SR142948A) on the scopolamine-induced deficits in a novel object discrimination task.
    Azmi N; Norman C; Spicer CH; Bennett GW
    Behav Pharmacol; 2006 Jun; 17(4):357-62. PubMed ID: 16914954
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Double dissociation of pharmacologically induced deficits in visual recognition and visual discrimination learning.
    Turchi J; Buffalari D; Mishkin M
    Learn Mem; 2008 Aug; 15(8):565-8. PubMed ID: 18685146
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Specific characteristics of cholinergic mechanisms of short-term memory in monkeys for different types of visual information: the effects of amizil.
    Dudkin KN; Chueva IV
    Neurosci Behav Physiol; 1999; 29(1):23-9. PubMed ID: 10088146
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.